MY127711A - Anti-vaginitis compositions for topical use - Google Patents

Anti-vaginitis compositions for topical use

Info

Publication number
MY127711A
MY127711A MYPI97002126A MYPI9702126A MY127711A MY 127711 A MY127711 A MY 127711A MY PI97002126 A MYPI97002126 A MY PI97002126A MY PI9702126 A MYPI9702126 A MY PI9702126A MY 127711 A MY127711 A MY 127711A
Authority
MY
Malaysia
Prior art keywords
vaginitis
compositions
topical use
benzocaine
miconazole
Prior art date
Application number
MYPI97002126A
Other languages
English (en)
Inventor
Embil Koral
Morton Oswald
Original Assignee
Edko Trading Representation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10793879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY127711(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Edko Trading Representation filed Critical Edko Trading Representation
Publication of MY127711A publication Critical patent/MY127711A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MYPI97002126A 1996-05-17 1997-05-15 Anti-vaginitis compositions for topical use MY127711A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9610359.3A GB9610359D0 (en) 1996-05-17 1996-05-17 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MY127711A true MY127711A (en) 2006-12-29

Family

ID=10793879

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI97002126A MY127711A (en) 1996-05-17 1997-05-15 Anti-vaginitis compositions for topical use

Country Status (12)

Country Link
EP (1) EP0910377A1 (fr)
JP (1) JP2000513334A (fr)
CN (1) CN1127338C (fr)
AU (1) AU2905597A (fr)
BR (1) BR9709316A (fr)
GB (1) GB9610359D0 (fr)
ID (1) ID16929A (fr)
MY (1) MY127711A (fr)
RU (1) RU2195281C2 (fr)
TR (1) TR199802351T2 (fr)
WO (1) WO1997044032A1 (fr)
ZA (1) ZA974266B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2777783A1 (fr) * 1998-04-24 1999-10-29 Innothera Lab Sa Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
CN1852690B (zh) 2003-09-19 2010-04-14 制药技术有限公司 药物输送系统
US8309103B2 (en) * 2004-01-22 2012-11-13 Alparis, S.A. De C.V. Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage
GB0405406D0 (en) * 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
MX2007013631A (es) * 2005-05-09 2008-01-24 Drugtech Corp Composiciones farmaceuticas de liberacion modificada.
CN1291754C (zh) * 2005-07-12 2006-12-27 李赴朝 局麻药增效延时剂
US20070154516A1 (en) * 2006-01-05 2007-07-05 Drugtech Corporation Drug delivery system
WO2007079389A2 (fr) * 2006-01-05 2007-07-12 Drugtech Corporation Composition et méthode d'utilisation de celle-ci
RU2605343C1 (ru) * 2015-11-30 2016-12-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
RU2603490C1 (ru) * 2015-11-30 2016-11-27 Государственное бюджетное образовательное учреждение высшего профессионального образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Средство для лечения гнойно-воспалительных процессов мягких тканей и слизистых оболочек
PT3481370T (pt) 2016-07-08 2021-05-28 Acraf Composição farmacêutica compreendendo benzidamina

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8830405D0 (en) * 1988-12-30 1989-03-01 Embil Koral Pharmaceutical formulation

Also Published As

Publication number Publication date
CN1127338C (zh) 2003-11-12
ID16929A (id) 1997-11-20
CN1223581A (zh) 1999-07-21
RU2195281C2 (ru) 2002-12-27
ZA974266B (en) 1998-11-16
GB9610359D0 (en) 1996-07-24
BR9709316A (pt) 2000-05-02
TR199802351T2 (xx) 1999-03-22
AU2905597A (en) 1997-12-09
JP2000513334A (ja) 2000-10-10
EP0910377A1 (fr) 1999-04-28
WO1997044032A1 (fr) 1997-11-27

Similar Documents

Publication Publication Date Title
MY127711A (en) Anti-vaginitis compositions for topical use
MY132705A (en) Novel compounds with analgesic effect
MY115662A (en) Novel compounds with analgesic effect
GB2340039B (en) Improved delivery of drugs to mucosal surfaces
ATE285237T1 (de) Zusammensetzung die tramadol und ein nichtsteroides entzündungshemmenden mittel enthält
MY119365A (en) Novel pharmaceutical combination
AU1890295A (en) Piperidines and pyrrolidines
AU2931500A (en) Pharmaceutical composition containing nitrate source and an acidifying agent fortreating skin ischaemia
MD960330A (ro) Compuşi nepeptidilici, compoziţie farmaceutică pe baza acestora, metodă de tratament
YU19001A (sh) Stabilne tečne formulacije botulinskog otrova
CA2258920A1 (fr) Acide hyaluronique autoreticule et compositions pharmaceutiques associees pour le traitement des arthropathies
ES2161288T3 (es) Comprimido revestido con polimero que comprende amoxicilina y clavulanato.
RS49721B (sr) Kompozicija koja sadrži biljku i površinski aktivno sredstvo korisna u proizvodnji proizvoda za tretiranje herpesa i drugih mikrobnih infekcija
GB8607159D0 (en) Pharmaceutical composition
EP0161816A3 (fr) Urogastrone
AU2104900A (en) Composition used as medicine and use of same for obtaining medicine for anaesthesia, in particular analgesic medicine
AU1026399A (en) Pharmaceutical compositions containing ricinoleic acid and their use in anti-inflammatory and analgesic therapy
WO1999020259A3 (fr) Compositions contenant thiamphenicol et diclofenac
WO2001022917A3 (fr) Compositions effervescentes comportant du nimesulide
HUT74460A (en) Pharmaceutical composition for psoriasis treatment
WO1999003509A3 (fr) Agents pharmaceutiques contenant des triiodoaromatiques contenant des groupes perfluoroalkyle et leur utilisation dans le traitement de tumeurs et en radiologie exploratrice
AU6037494A (en) Use of active substances in the therapy of certain diseases, process for preparing a pharmaceutical composition for that purpose and pharmaceutical compositions thus prepared
IT1264428B1 (it) Composizioni farmaceutiche per il trattamento della psoriasi
UA23046C2 (uk) Протимікробhий засіб
IL103313A (en) Pharmaceutical compositions comprising a tramadol material and acetaminophen